← All stocks

Stock news timeline · MANKIND

Mankind Pharma Ltd

News timeline · Last 30 days

23 Aug 2026 – 21 Sep 2026 · Times in IST

Timeline updates
13
Bullish
1
Neutral
11
Bearish
1
Active days
8

News timeline

Showing 13 of 13 updates · Newest first

Tuesday, 15 Sep 20261 update

AI sentiment: Bullish 78% confidence

Mankind Pharma: Gets ESG Rating Of 68.21 From Niche99 In Leader Category For FY26

Friday, 11 Sep 20262 updates

AI sentiment: Neutral 66% confidence

Mankind Pharma to Join Key Investor Conferences

Mankind Pharma announces participation in investor conferences, including Jefferies India Forum and J.P. Morgan India Conference. No unpublished price-sensitive info will be disclosed; focus on general business outlook. Source: BSE

AI sentiment: Neutral 76% confidence

Mankind Pharma Block Trade Worth ₹41 Cr at ₹2,254.6/Share

Mankind Pharma executed an NSE block trade worth Rs. 41.05 Cr. The trade involved 182,074 shares at a price of Rs. 2,254.6. Source: Livesquawk

Wednesday, 09 Sep 20261 update

AI sentiment: Bearish 94% confidence

Mankind Pharma Falls 5th Day, Down 12.6% YoY

Mankind Pharma drops for 5th session, trading at Rs 2280.2, down 1.25% today. Stock is down 12.6% YoY vs Nifty's 5.7% drop and Nifty Pharma's 20.8% rise. Source: Business Standard

Monday, 07 Sep 20262 updates

AI sentiment: Neutral 91% confidence

Mankind Pharma: Subsidiary Bharat Serums And Vaccines Gets Approval For Voluntary Liquidation Pending Creditor Consent.

AI sentiment: Neutral 63% confidence

Mankind Pharma Unit Bharat Serums to Liquidate Pending Creditor Consent

Mankind Pharma's subsidiary Bharat Serums approved for voluntary liquidation. Liquidation subject to creditor consent and aligns with regulatory norms. Source: ScoutQuest

Tuesday, 01 Sep 20261 update

AI sentiment: Neutral 92% confidence

Mankind Pharma Allots 49,112 ESOP Shares at ₹860 Each

Mankind Pharma Ltd allotted 49,112 equity shares under ESOP Plan 2022, raising paid-up share capital to 41.30 crore shares. New shares will rank pari-passu with existing ones; exercise price per share set at ₹860, with a premium of ₹859. Source: BSE

Monday, 31 Aug 20262 updates

AI sentiment: Neutral 92% confidence

Mankind Pharma: Sells Entire Stake In Broadway Hospitality To AKRK Projects.

AI sentiment: Neutral 92% confidence

Mankind Pharma Sells Broadway Stake, Ends Subsidiary Status by 2026

Mankind Pharma sold 100% stake in Broadway Hospitality Services to AKRK Projects LLP. Broadway ceases to be Mankind Pharma's subsidiary from August 31, 2026. Source: ScoutQuest

Sunday, 30 Aug 20261 update

AI sentiment: Neutral 92% confidence

Mankind Pharma's Bharat Anand to Conclude Independent Director Role by Aug 2026

Mankind Pharma announced the completion of Mr. Bharat Anand's tenure as Independent Director on Aug 30, 2026. He also ceased to be a member of key committees; Board acknowledged his contributions. Source: BSE

Wednesday, 26 Aug 20263 updates

AI sentiment: Neutral 82% confidence

Mankind Pharma to Wind Down Bharat Serums for Streamlined Operations

Mankind Pharma's board approved winding down subsidiary Bharat Serums and Vaccines. The move aims to simplify operations and refocus capital allocation. Source: Livesquawk

AI sentiment: Neutral 81% confidence

Mankind Pharma to Liquidate BSVL, Consolidates Business

Mankind Pharma's board approved voluntary liquidation of subsidiary BSVL, holding 96% shares. BSVL's business to consolidate with Mankind Pharma, Appian to receive cash for 4% shares. Source: BSE

AI sentiment: Neutral 93% confidence

Mankind Pharma: Board Consents to Wind Down Subsidiary Bharat Serums and Vaccines